Your browser doesn't support javascript.
loading
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.
Goetze, Sandra; Schüffler, Peter; Athanasiou, Alcibiade; Koetemann, Anika; Poyet, Cedric; Fankhauser, Christian Daniel; Wild, Peter J; Schiess, Ralph; Wollscheid, Bernd.
Afiliación
  • Goetze S; Department of Health Sciences and Technology, Institute of Translational Medicine, Swiss Federal Institute of Technology, ETH Zurich, 8093, Zurich, Switzerland.
  • Schüffler P; Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland.
  • Athanasiou A; ETH PHRT Swiss Multi-Omics Center (SMOC), 8093, Zurich, Switzerland.
  • Koetemann A; Institute of General and Surgical Pathology, Technical University of Munich, 81675, Munich, Germany.
  • Poyet C; Proteomedix AG, 8952, Schlieren, Switzerland.
  • Fankhauser CD; Department of Health Sciences and Technology, Institute of Translational Medicine, Swiss Federal Institute of Technology, ETH Zurich, 8093, Zurich, Switzerland.
  • Wild PJ; Clinic of Urology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland.
  • Schiess R; Clinic of Urology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland.
  • Wollscheid B; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland. Peter.Wild@kgu.de.
Clin Proteomics ; 19(1): 9, 2022 Apr 27.
Article en En | MEDLINE | ID: mdl-35477343

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Proteomics Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Proteomics Año: 2022 Tipo del documento: Article País de afiliación: Suiza